Effects of Different Occlusion Angles of Disposable Tracheal Blocker on Right One-lung Ventilation
Launched by CHINA MEDICAL UNIVERSITY, CHINA · Sep 10, 2024
Trial Information
Current as of November 13, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different angles of a disposable tracheal blocker affect the way patients breathe during right lung surgery. The study will be done at three hospitals in China, South Korea, and Serbia, and aims to find the best way to help patients breathe using this device. The trial is currently recruiting participants who are between 18 and 65 years old and are scheduled for right thoracoscopic surgery, which is a type of minimally invasive surgery on the chest.
To be eligible for the study, participants should have good overall health (ASA grades I-III) and no serious history of lung or heart problems. They should also have a good level of oxygen in their blood before surgery. If someone joins the study, they can expect to be randomly placed into one of two groups, each using the tracheal blocker at different angles. This research could help improve breathing techniques during surgery and enhance patient safety.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ranged from 18 to 65 years old;
- • American Society of Anesthesiologists (ASA) grade I-III;
- • No history of drug allergy or abnormal anesthesia;
- • Patients undergoing right thoracoscopic surgery;
- • The preoperative oxygen saturation was not less than 94%.
- Exclusion Criteria:
- • Patients with a history of acute lung injury or ARDS within 3 months;
- • Cardiac function class IV (New York Heart Association classification);
- • Chronic renal failure (renal cell filtration rate \<30ml min-11.73m-2), severe liver disease;
- • Patients with blurred consciousness and cognitive dysfunction;
- • Patients with severe coagulation dysfunction;
- • Without preoperative oxygen inhalation, blood oxygen \<94%, severe pulmonary dysfunction;
- • Patients with endotracheal tube admitted to ICU after operation;
- • Body mass index (BMI) \>30;
- • Patients who had had lung surgery;
- • Inability to complete the study;
About China Medical University, China
China Medical University, located in Shenyang, China, is a prestigious institution dedicated to advancing medical education, research, and healthcare innovation. Renowned for its commitment to excellence, the university plays a pivotal role in clinical research and trials, leveraging its comprehensive medical expertise and state-of-the-art facilities. With a focus on enhancing patient care and outcomes, China Medical University fosters collaboration between researchers, healthcare professionals, and industry partners to address critical health challenges and contribute to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, Korea, Republic Of
Shenyang, China
Belgrade, Serbia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported